← Dolby Laboratories, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $185.9m |
$201.8m
+8.58%
|
$122.2m
-39.42%
|
$255.2m
+108.72%
|
$231.4m
-9.32%
|
$310.2m
+34.09%
|
$184.1m
-40.66%
|
$200.7m
+9.00%
|
$261.8m
+30.48%
|
$255.0m
-2.60%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $186.4m | $202.4m | $122.8m | $255.5m | $231.6m | $317.8m | $183.9m | $201.6m | $264.3m | $256.5m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $542k | $625k | $559k | $354k | $256k | $7.6m | ($189k) | — | — | — | — | |
| Depreciation and amortization | $85.2m | $84.3m | $81.3m | $85.1m | $90.9m | $95.9m | $88.5m | $82.6m | $75.6m | $87.8m | $103.3m | |
| Amortization of Intangible Assets | $33.2m | $30.9m | $26.5m | $29.7m | $29.5m | $29.5m | $29.0m | $28.6m | $33.2m | $45.3m | — | |
| Depreciation | $52.0m | $53.4m | $54.8m | $55.5m | $61.4m | $66.4m | $59.5m | $54.0m | $42.4m | $42.5m | $103.3m | |
| Deferred Income Tax Expense (Benefit) | ($22.8m) | ($29.4m) | $89.9m | ($40.2m) | ($5.3m) | ($37.0m) | ($29.5m) | ($18.3m) | ($21.6m) | $5.0m | $15.7m | |
| Share-based Payment Arrangement, Noncash Expense | $67.0m | $65.3m | $71.2m | $76.6m | $86.6m | $99.7m | $114.9m | $118.5m | $119.8m | $128.5m | $129.9m | |
| Share-based Payment Arrangement, Expense | $67.0m | $65.3m | $71.2m | $76.6m | $86.6m | $99.7m | $114.9m | $118.5m | $119.8m | $128.5m | $129.9m | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $5.0m | $5.1m | $14.2m | — | — | |
| Nonoperating Income (Expense) | $4.1m | $8.0m | $12.9m | $25.2m | $21.0m | $10.1m | $8.7m | $34.3m | $54.2m | $38.5m | — | |
| Other Nonoperating Income (Expense) | ($1.4m) | ($1.4m) | ($5.9m) | $481k | $8.4m | $7.1m | $2.5m | $6.2m | $20.1m | $23.1m | — | |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | — | — | — | — | — | — | — | — | — | $707k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($24.9m) | ($1.0m) | $65.7m | $27.5m | ($1.3m) | $49.0m | $14.3m | ($47.8m) | $29.0m | $18.5m | ($37.1m) | |
| Increase (Decrease) in Inventories | $2.9m | $11.9m | $6.6m | $16.1m | $11.8m | ($17.2m) | $11.8m | $13.2m | $2.7m | ($8.0m) | $10.5m | |
| Net Cash Provided by (Used in) Operating Activities | $356.8m |
$371.1m
+3.98%
|
$352.2m
-5.08%
|
$327.7m
-6.96%
|
$343.8m
+4.94%
|
$447.8m
+30.22%
|
$318.6m
-28.85%
|
$367.1m
+15.23%
|
$327.3m
-10.85%
|
$472.2m
+44.29%
|
$437.6m
-7.33%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $100.8m | $99.6m | $72.8m | $96.3m | $66.3m | $54.5m | $47.9m | $30.3m | $30.0m | $36.3m | ($93.1m) | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | — | — | — | — | $53.9m | $108.5m | $176.8m | $157.7m | $0 | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $0 | $22.9m | $14.9m | $0 | $4.5m | $38.2m | ($25.7m) | $487.9m | $1.4m | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($282.5m) | ($161.7m) | $78.2m | ($56.2m) | $134.4m | ($44.9m) | ($295.9m) | $54.2m | ($286.3m) | ($10.6m) | ($76.5m) | |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common Stock | $100.9m | $100.0m | $150.5m | $340.6m | $173.7m | $245.9m | $530.5m | $149.3m | $160.0m | $125.0m | — | |
| Payments of Ordinary Dividends, Common Stock | $48.4m | $57.1m | $66.2m | $77.5m | $88.6m | $89.2m | $100.1m | $103.4m | $114.6m | $126.6m | ($134.2m) | |
| Net Cash Provided by (Used in) Financing Activities | ($88.8m) |
($100.1m)
-12.76%
|
($133.6m)
-33.51%
|
($385.3m)
-188.32%
|
($207.8m)
+46.07%
|
($252.5m)
-21.53%
|
($610.6m)
-141.79%
|
($236.8m)
+61.21%
|
($287.8m)
-21.54%
|
($247.2m)
+14.10%
|
($376.8m)
-52.40%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | $274.4m | $153.1m | ($604.7m) | $189.6m | ($240.2m) | $215.6m | $740.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $805.6m | $1.1b | $1.2b | $628.4m | $818.0m | $577.8m | $793.4m | $740.8m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Additional Financial Items | ||||||||||||
| Deconsolidation, Gain (Loss), Amount | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | — | — | — | — | $24.1m | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | $13.9m | $0 | $0 | — | — | — | |
| General and Administrative Expense | $168.9m | $171.7m | $197.5m | $205.4m | $219.8m | $224.2m | $275.3m | $258.5m | $270.4m | $286.5m | — | |
| Goodwill | $309.6m | $311.1m | $328.0m | $334.8m | $336.9m | $340.7m | $365.1m | $408.4m | $533.2m | $529.9m | $0 | |
| Income Tax Expense (Benefit) | $49.5m | $54.2m | $190.1m | $26.8m | $8.1m | $36.7m | $31.4m | $48.4m | $48.2m | $47.0m | — | |
| Investment Income, Interest | $5.7m | $9.6m | $19.0m | $24.9m | $12.7m | $3.5m | $6.6m | — | — | — | — | |
| Operating Expenses | $685.0m | $714.5m | $743.7m | $823.7m | $796.6m | $806.8m | $905.8m | $931.4m | $874.9m | $924.0m | — | |
| Proceeds from (Payments to) Noncontrolling Interests | — | — | — | — | — | — | — | — | ($9.9m) | $0 | — | |
| Proceeds from Stock Options Exercised | $71.1m | $70.0m | $106.2m | $57.3m | $82.7m | $122.1m | $57.8m | $47.8m | $40.2m | $43.7m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.